# Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

> **NCT00595270** · PHASE3 · COMPLETED · sponsor: **Valneva Austria GmbH** · enrollment: 349 (actual)

## Conditions studied

- Japanese Encephalitis

## Interventions

- **BIOLOGICAL:** IC51

## Key facts

- **NCT ID:** NCT00595270
- **Lead sponsor:** Valneva Austria GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-09
- **Final completion:** 2009-04
- **Target enrollment:** 349 (ACTUAL)
- **Last updated:** 2014-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00595270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00595270, "Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00595270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*